Lv4
518 积分 2023-06-26 加入
CML-892: Switching Too Soon? Early vs Late TKI Switching: Real-World Analysis of Early TKI Modification in Chronic Myeloid Leukemia
8天前
已关闭
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
14天前
已完结
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
18天前
已完结
Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia
19天前
已完结
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results
19天前
已完结
Early Positron Emission Tomography Response-Adapted Treatment in Low-Risk Diffuse Large B-Cell lymphoma: an open label, multicenter, randomised, non-inferiority phase 3 trial
25天前
已关闭
Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era
25天前
已完结
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?
28天前
已完结
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?
29天前
已完结
Interim FDG-PET/CT for Response Assessment of Lymphoma
30天前
已完结
皖公网安备34019202002308
